Clearbridge Investments, LLC
Source: SEC Form 13F · as of Mar 2026Clearbridge Investments, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $1.42B in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$1.42B
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,356,036 | $448.7M |
| GILDGILEAD SCIENCES, INC. | 1,231,150 | $171.6M |
| ARGXARGENX SE | 231,356 | $168.9M |
| TGTXTG THERAPEUTICS, INC. | 3,210,930 | $106.7M |
| INSMINSMED Inc | 643,435 | $105.2M |
| BBIOBridgeBio Pharma, Inc. | 951,200 | $70.6M |
| PTGXProtagonist Therapeutics, Inc | 621,820 | $65.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 73,792 | $57.0M |
| ROIVRoivant Sciences Ltd. | 2,005,565 | $55.6M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 609,437 | $53.0M |
| SRRKScholar Rock Holding Corp | 691,418 | $34.0M |
| GERNGERON CORP | 19,620,320 | $29.2M |
| VKTXViking Therapeutics, Inc. | 444,781 | $14.5M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 202,347 | $12.7M |
| AXSMAxsome Therapeutics, Inc. | 45,020 | $7.6M |
| PCVXVaxcyte, Inc. | 128,377 | $7.5M |
| PVLAPALVELLA THERAPEUTICS, INC. | 59,410 | $7.4M |
| BCAXBicara Therapeutics Inc. | 289,221 | $5.8M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 22,240 | $1.2M |
| SNYSanofi | 6,689 | $322K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.